These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 27868295

  • 1. Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Zhang F, Wang Y, Wang ZQ, Sun P, Wang DS, Jiang YX, Zhang DS, Wang FH, Xu RH, Li YH.
    Dis Esophagus; 2017 Feb 01; 30(2):1-8. PubMed ID: 27868295
    [Abstract] [Full Text] [Related]

  • 2. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
    Kajiura S, Hosokawa A, Yoshita H, Ueda Y, Ueda A, Mihara H, Ando T, Fujinami H, Nishikawa J, Ogawa K, Minemura M, Sugiyama T.
    Am J Clin Oncol; 2016 Feb 01; 39(1):13-7. PubMed ID: 24322336
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study.
    Wang ZQ, Wang DS, Wang FH, Ren C, Tan Q, Li YH.
    Invest New Drugs; 2021 Apr 01; 39(2):516-523. PubMed ID: 33070249
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
    Fujita Y, Hiramatsu M, Kawai M, Sumiyoshi K, Nishimura H, Tanigawa N.
    Dis Esophagus; 2008 Apr 01; 21(6):496-501. PubMed ID: 18840134
    [Abstract] [Full Text] [Related]

  • 5. Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
    Jin J, Xu X, Wang F, Yan G, Liu J, Lu W, Li X, Tucker SJ, Zhong B, Cao Z, Wang D.
    J Thorac Oncol; 2009 Aug 01; 4(8):1017-21. PubMed ID: 19542899
    [Abstract] [Full Text] [Related]

  • 6. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T, Yamanaka T, Seto T, Daga H, Goto K, Saka H, Sugawara S, Takahashi T, Yokota S, Kaneda H, Kawaguchi T, Nagase S, Oguri T, Iwamoto Y, Nishimura T, Hattori Y, Nakagawa K, Nakanishi Y, Yamamoto N, West Japan Oncology Group.
    Lancet Oncol; 2015 Dec 01; 16(16):1630-8. PubMed ID: 26522337
    [Abstract] [Full Text] [Related]

  • 7. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
    Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C.
    Int J Clin Oncol; 2006 Dec 01; 11(6):454-60. PubMed ID: 17180514
    [Abstract] [Full Text] [Related]

  • 8. Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial.
    Lu M, Wang X, Shen L, Jia J, Gong J, Li J, Li J, Li Y, Zhang X, Lu Z, Zhou J, Zhang X.
    Cancer Sci; 2016 Apr 01; 107(4):486-90. PubMed ID: 26797530
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
    Miyawaki Y, Nakajima Y, Kawada K, Okada T, Tokairin Y, Kawano T.
    Dis Esophagus; 2017 Feb 01; 30(2):1-8. PubMed ID: 27001629
    [Abstract] [Full Text] [Related]

  • 10. A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.
    Wang HY, Yao ZH, Tang H, Zhao Y, Jin SL, Zhou WP, Yao SN, Yang SJ, Liu YY, Luo SX.
    Oncotarget; 2017 Jan 31; 8(5):7540-7547. PubMed ID: 27902478
    [Abstract] [Full Text] [Related]

  • 11. A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.
    He YF, Ji CS, Hu B, Fan PS, Hu CL, Jiang FS, Chen J, Zhu L, Yao YW, Wang W.
    World J Gastroenterol; 2013 Sep 21; 19(35):5910-6. PubMed ID: 24124338
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
    Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y.
    Curr Med Res Opin; 2013 Feb 21; 29(2):117-25. PubMed ID: 23216340
    [Abstract] [Full Text] [Related]

  • 13. Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study.
    Lee SJ, Kim S, Kim M, Lee J, Park YH, Im YH, Park SH.
    BMC Cancer; 2015 Oct 14; 15():693. PubMed ID: 26468007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer.
    Du J, Hu C, Zhang Y, Hu B, Wang F, Zhang Y.
    Anticancer Drugs; 2015 Jan 14; 26(1):101-5. PubMed ID: 25222530
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.
    Tian D, Zhang L, Wang Y, Chen L, Zhang KP, Zhou Y, Wen HY, Fu MY.
    Dis Esophagus; 2019 Mar 01; 32(3):. PubMed ID: 30247659
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.